Literature DB >> 25773152

HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.

Yan Sun1, Huoying Chen2, Jiapei Dai3, Huijuan Zou2, Ming Gao2, Hao Wu2, Bingxia Ming2, Lin Lai2, Yifan Xiao2, Ping Xiong2, Yong Xu2, Feili Gong2, Fang Zheng4.   

Abstract

High mobility group box 1 (HMGB1), a nonhistone chromatin associated protein, plays different roles according to the expression pattern such as the amount, cell location and sub-cellular location. It has been recently demonstrated that the systemic HMGB1 is associated with autoimmune encephalomyelitis. However, the dynamic change of HMGB1 expression pattern in spinal cords that may be involved in the progression of disease is not fully understood. In this study, the amount, cell location and subcellular location of HMGB1 in adult mice spinal cords during various stages of experimental autoimmune encephalomyelitis (EAE) are investigated. HMGB1 is expressed in the nuclei of spinal cord resident cells such as some astrocytes, microglia and a few neurons in normal situation. During EAE progression, the total and extracellular HMGB1 in the spinal cord are increased, more HMGB1 positive astrocytes and microglia are observed, and the intra-neurons HMGB1 in the ventral horn and around the central canal localize majorly in the cytoplasm accompanied by the increasing extracellular HMGB1. Blockade of HMGB1 in central nervous system (CNS) locally attenuates the severity of EAE significantly. Our findings indicate that the HMGB1 expression pattern in the spinal cord is associated with the progression of EAE. HMGB1 may be a potential target for autoimmune encephalomyelitis (multiple sclerosis in human) therapy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocyte; Experimental autoimmune encephalomyelitis; High mobility group box 1; Microglia; Neuron

Mesh:

Substances:

Year:  2015        PMID: 25773152     DOI: 10.1016/j.jneuroim.2015.02.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation.

Authors:  Kristina A Kigerl; Wenmin Lai; Lindsay M Wallace; Huan Yang; Phillip G Popovich
Journal:  Brain Behav Immun       Date:  2017-11-23       Impact factor: 7.217

2.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  High-mobility group box-1 as an autocrine trophic factor in white matter stroke.

Authors:  Jun Young Choi; Yuexian Cui; Samma Tasneem Chowdhury; Byung Gon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

4.  TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.

Authors:  Masato Tsutsui; Ryo Hirase; Sakie Miyamura; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-09-10       Impact factor: 6.167

5.  Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis.

Authors:  Alexandra M Nicaise; Laura J Wagstaff; Cory M Willis; Carolyn Paisie; Harshpreet Chandok; Paul Robson; Valentina Fossati; Anna Williams; Stephen J Crocker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

6.  HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes.

Authors:  Yifan Xiao; Yan Sun; Wei Liu; FanFan Zeng; Junyu Shi; Jun Li; Huoying Chen; Chang Tu; Yong Xu; Zheng Tan; Feili Gong; Xiji Shu; Fang Zheng
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 7.  The Role of Astrocytes in Multiple Sclerosis Progression.

Authors:  Jorge Correale; Mauricio F Farez
Journal:  Front Neurol       Date:  2015-08-18       Impact factor: 4.003

Review 8.  HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.

Authors:  Yam Nath Paudel; Mohd Farooq Shaikh; Ayanabha Chakraborti; Yatinesh Kumari; Ángel Aledo-Serrano; Katina Aleksovska; Marina Koutsodontis Machado Alvim; Iekhsan Othman
Journal:  Front Neurosci       Date:  2018-09-11       Impact factor: 4.677

9.  Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release.

Authors:  Yan Sun; Huoying Chen; Jiapei Dai; Zhongjun Wan; Ping Xiong; Yong Xu; Zhengrong Han; Weitai Chai; Feili Gong; Fang Zheng
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

Review 10.  Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1.

Authors:  Carolina M Gorgulho; Graziela G Romagnoli; Rosh Bharthi; Michael T Lotze
Journal:  Front Immunol       Date:  2019-07-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.